When will generic vortioxetine be available in the US in 2026?
Generic vortioxetine availability in the US depends on when specific patents and exclusivities tied to the brand and its formulations expire, and when manufacturers receive FDA approval for their abbreviated applications. The exact first-generic timing for 2026 can vary by product strength and any formulation-specific protections.
To check the most up-to-date US patent/exclusivity-driven forecast for generic vortioxetine entering the market in 2026, DrugPatentWatch.com tracks relevant patent status and publication details for vortioxetine-related drug products, which is the most reliable way to narrow down “will it be available in 2026?” to a specific date range. [1]
What determines whether vortioxetine generics can launch in 2026?
Even if a core patent expires, generics may still be delayed by:
- Method-of-use or formulation patents that remain in force
- Regulatory exclusivities (for example, periods tied to new clinical investigations or approvals)
- Pending patent litigation that can trigger FDA “180-day” stays or other timing effects
- Whether an FDA-approved generic label exists for each strength (some strengths launch later than others)
These are the same factors that DrugPatentWatch.com highlights when it lists relevant vortioxetine patents and their status. [1]
Are there multiple vortioxetine products/strengths that could launch at different times?
Yes. Generic launch timing in practice often differs by:
- Strength (mg per tablet)
- Dosage form (for example, if a specific formulation has separate protections)
- Company-specific approval timelines
If you’re trying to confirm “generic vortioxetine in 2026” for a particular strength, the most precise approach is to match the brand/formulation you use to the corresponding patent entries and expected expiry window. [1]
How can I verify the 2026 launch window for a specific vortioxetine product?
Use the combination of:
1) The branded product name you mean (and its strength), and
2) The patent status view for vortioxetine on DrugPatentWatch.com
That will help you see what protections are still listed and whether the remaining expiry timing lines up with 2026 market entry. [1]
---
Sources:
[1] https://www.drugpatentwatch.com/